Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
Jul 26, 2017 Auen, Eileen Director Acquisition (Non Open Market) 7,976 n/a
May 22, 2012 Avista, Capital Beneficial Owner (10% or more) Statement of Ownership 0 n/a
May 22, 2012 Burgstahler, David Director Statement of Ownership 0 n/a
Aug 7, 2012 Burgstahler, David Director Acquisition (Non Open Market) 2,850 n/a
Aug 6, 2013 Burgstahler, David Director Acquisition (Non Open Market) 3,000 n/a
Oct 23, 2013 Burgstahler, David Director Acquisition (Non Open Market) 1,616 n/a
Aug 12, 2014 Burgstahler, David Director Acquisition (Non Open Market) 6,193 n/a
Jul 22, 2015 Burgstahler, David Director Acquisition (Non Open Market) 5,266 n/a
Jul 27, 2016 Burgstahler, David Director Acquisition (Non Open Market) 5,063 n/a
Apr 26, 2017 Campbell, Chad Officer Statement of Ownership 0 n/a
Jul 26, 2017 Campbell, Chad Officer Acquisition (Non Open Market) 3,342 n/a
Apr 4, 2016 Clemmer, James Officer Acquisition (Non Open Market) 50,000 n/a
Jul 27, 2016 Clemmer, James Officer Acquisition (Non Open Market) 21,191 n/a
Jul 26, 2017 Clemmer, James Officer Acquisition (Non Open Market) 22,092 n/a
Sep 7, 2011 Devivo, Joseph Officer Acquisition (Non Open Market) 25,000 n/a
Aug 7, 2012 Devivo, Joseph Officer Acquisition (Non Open Market) 2,850 n/a
Aug 17, 2012 Devivo, Joseph Officer Acquisition (Non Open Market) 22,247 n/a
Aug 6, 2013 Devivo, Joseph Officer Acquisition (Non Open Market) 18,388 n/a
Dec 20, 2013 Devivo, Joseph Officer Acquisition (Non Open Market) 80,000 n/a
Jul 25, 2014 Devivo, Joseph Officer Acquisition (Non Open Market) 30,884 n/a
Showing 1-20 of 248 transactions Page: 1 2 3 ... 13   See Next 20

Stock transaction information provided by EDGAR Online. AngioDynamics makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

  • Stock Information
  • Ticker ANGO
    Exchange NASDAQ
    Price $17.99
    Change + 0.04
    Volume 223,885
    Sep 26, 2017 - 3:50 PM ET
  • Search Investor Relations